Picard Medical, INC. 8-K Filing
Ticker: PMI · Form: 8-K · Filed: Nov 26, 2025 · CIK: 2030617
Sentiment: neutral
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-11-26 07:15:44
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PMI The NYSE American, LL
Filing Documents
- picardmedical_8k.htm (8-K) — 31KB
- picardmedical_ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 13KB
- 0001829126-25-009457.txt ( ) — 227KB
- pmi-20251126.xsd (EX-101.SCH) — 3KB
- pmi-20251126_lab.xml (EX-101.LAB) — 33KB
- pmi-20251126_pre.xml (EX-101.PRE) — 22KB
- picardmedical_8k_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On November 26, 2025, Picard Medical, Inc. issued a press release announcing that Duffy Elmer will present in vitro data on the Emperor Total Artificial Heart at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support in Vienna, Austria between December 1 and 4, 2025. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein. The information in this report and the exhibits attached hereto shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press Release dated November 26, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Picard Medical, Inc. By: /s/ Patrick NJ Schnegelsberg Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer Dated: November 26, 2025 2